Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 44.00
+1.15 (2.68%)
At close: Dec 31, 2025
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 3.92 billion as of December 31, 2025. Its market cap has decreased by -2.55% in one year.
Market Cap
3.92B
Enterprise Value
3.12B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.00
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 3.92B, a decrease of -42.39%. That is a compound annual growth rate of -4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |